In Silico Molecular Docking of Murraya koenigii (L.) Spreng. Metabolites against the Androgen Receptor
Prostate cancer is strongly driven by androgen receptor (AR) signaling, making the AR ligand-binding domain an important therapeutic target. Murraya koenigii (L.) Spreng. contains diverse secondary metabolites with reported pharmacological activities, but their interaction with AR remains insufficiently characterized....